NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-154

  1. 942 Posts.
    lightbulb Created with Sketch. 156
    Steed, I suspect he'll reply to every text too considering how polite he has been in the past in responding to individual queries.
    BTW -I just signed up to Acadia email alert for press releases (2 minute exercise). i'm guessing the next release will be a seminal moment in the history of a small NZ/Aus pharma hitting the world stage.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.